These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 9435188)

  • 21. A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1559-67. PubMed ID: 17505840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
    Lee KC; Silver PJ; Bode DC; Gherezghiher T
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits.
    Stagni E; Privitera MG; Bucolo C; Leggio GM; Motterlini R; Drago F
    Br J Ophthalmol; 2009 Feb; 93(2):254-7. PubMed ID: 18977789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes.
    Bito LZ; Draga A; Blanco J; Camras CB
    Invest Ophthalmol Vis Sci; 1983 Mar; 24(3):312-9. PubMed ID: 6572617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of central corneal thickness on the efficacy of topical ocular hypotensive medications.
    Johnson TV; Toris CB; Fan S; Camras CB
    J Glaucoma; 2008 Mar; 17(2):89-99. PubMed ID: 18344753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symmetry of fellow-eye intraocular pressure responses to topical glaucoma medications.
    Realini T; Vickers WR
    Ophthalmology; 2005 Apr; 112(4):599-602. PubMed ID: 15808250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
    Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of calcium channel blockers for glaucoma.
    Araie M; Mayama C
    Prog Retin Eye Res; 2011 Jan; 30(1):54-71. PubMed ID: 20933604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical verapamil and episcleral venous pressure.
    Abreu MM; Kim YY; Shin DH; Netland PA
    Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexmedetomidine-induced ocular hypotension in rabbits with normal or elevated intraocular pressures.
    Vartiainen J; MacDonald E; Urtti A; Rouhiainen H; Virtanen R
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):2019-23. PubMed ID: 1349879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the topically applied calcium-channel blocker flunarizine on intraocular pressure in clinically normal dogs.
    Greller AL; Hoffman AR; Liu C; Ying GS; Vudathala DK; Acland GM; Komáromy AM
    Am J Vet Res; 2008 Feb; 69(2):273-8. PubMed ID: 18241026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
    Ishibashi S; Hirose N; Tawara A; Kubota T
    J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid-induced ocular hypertension in the rabbit: a model using subconjunctival injections.
    Hester DE; Trites PN; Peiffer RL; Petrow V
    J Ocul Pharmacol; 1987; 3(3):185-9. PubMed ID: 3503913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with alpha-chymotrypsin-induced ocular hypertension.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):322-8. PubMed ID: 11981648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
    Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
    Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity.
    Osborne NN; Wood JP; Cupido A; Melena J; Chidlow G
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1456-64. PubMed ID: 11980861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to control measurement variation in estimating the mean intraocular pressure reducing effect at a specific point in time.
    Hedman K; Taube A
    Contemp Clin Trials; 2005 Jun; 26(3):402-15. PubMed ID: 15911474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oculohypotensive effect of perindopril in acute and chronic models of glaucoma in rabbits.
    Mehta A; Iyer L; Parmar S; Shah G; Goyal R
    Can J Physiol Pharmacol; 2010 May; 88(5):595-600. PubMed ID: 20555429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of topical administration of 1% brinzolamide on intraocular pressure in clinically normal horses.
    Germann SE; Matheis FL; Rampazzo A; Burger D; Roos M; Spiess BM
    Equine Vet J; 2008 Nov; 40(7):662-5. PubMed ID: 18487097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
    Russell KR; Wang DR; Potter DE
    Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.